Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C

Clinical trial NCT02640547 · COMPLETED

Trial details

NCT number: NCT02640547
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Hepatitis C

Start date: 2015-11-26
Primary completion: 2017-03-29
Enrollment: 394

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.